Aptevo Therapeutics Inc. - 10-Q Filing
Aptevo Therapeutics reports Q3 2026 financial results featuring significant equity-based activity including Niowave warrants and standby equity purchase agreements.
Tickers: $APVO
Aptevo Therapeutics reports Q3 2026 financial results featuring significant equity-based activity including Niowave warrants and standby equity purchase agreements.
Tickers: $APVO